La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Guangzheng Eye Hospital GroupLtd Gestione

Gestione criteri di controllo 3/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Yonglin Zhou

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	16.3yrs
Proprietà del CEO	0.05%
Durata media del management	6.3yrs
Durata media del Consiglio di amministrazione	4.6yrs

Aggiornamenti recenti sulla gestione

Recent updates

Guangzheng Eye Hospital Group Co.,Ltd. (SZSE:002524) May Have Run Too Fast Too Soon With Recent 28% Price Plummet

Jun 06

Guangzheng Eye Hospital Group Co., Ltd.'s (SZSE:002524) Shares Climb 26% But Its Business Is Yet to Catch Up

Mar 18

AMMINISTRATORE DELEGATO

Yonglin Zhou (58 yo)

16.3yrs

Mandato

CN¥773,900

Compensazione

Mr. Yonglin Zhou is Chairman and General Manager of Guangzheng Eye Hospital Group Co., Ltd and has been its Director since June 25, 2008.

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Yonglin Zhou	Chairman & GM	no data	CN¥773.90k	0.053% CN¥ 1.1m
Li Junying	CFO & Director	13yrs	CN¥441.20k	0.078% CN¥ 1.7m
Jianmin Wang	Deputy GM & Director	no data	CN¥22.20k	0.068% CN¥ 1.5m
Tiejun Wang	Deputy GM & Non-Independent Director	6.3yrs	CN¥553.50k	0.097% CN¥ 2.1m
Wenling Wang	Acting Board Secretary & Chief Economist	2.5yrs	CN¥163.00k	0.0023% CN¥ 48.6k
Zhifang Chen	Deputy General Manager	no data	Nessun dato	0.037% CN¥ 790.3k

6.3yrs

Durata media

51yo

Età media

Gestione esperta: Il team dirigenziale di 002524 è esperto e expertise (durata media dell'incarico 6.1 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Yonglin Zhou	Chairman & GM	16.3yrs	CN¥773.90k	0.053% CN¥ 1.1m
Li Junying	CFO & Director	2.9yrs	CN¥441.20k	0.078% CN¥ 1.7m
Jianmin Wang	Deputy GM & Director	6.3yrs	CN¥22.20k	0.068% CN¥ 1.5m
Tiejun Wang	Deputy GM & Non-Independent Director	2.9yrs	CN¥553.50k	0.097% CN¥ 2.1m
Xin Feng	Non-Independent Director	16.3yrs	CN¥10.00k	Nessun dato
Yong Wang	Non-Independent Director	16.3yrs	CN¥10.00k	Nessun dato
Hongxin Yang	Chairman of the Supervisory Board	6.3yrs	Nessun dato	0.0040% CN¥ 85.2k
Yitao Song	Non-Employee Supervisor	2.9yrs	Nessun dato	Nessun dato
Aimin Yan	Independent Director	2.9yrs	Nessun dato	Nessun dato
Jian Ge	Independent Director	2.9yrs	Nessun dato	Nessun dato
Shiqiao Zheng	Independent Director	2.9yrs	Nessun dato	Nessun dato
Weili Li	Supervisor	6.3yrs	Nessun dato	0.0024% CN¥ 51.6k

4.6yrs

Durata media

55.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di 002524 sono considerati esperti (durata media dell'incarico 4.5 anni).

Guangzheng Eye Hospital GroupLtd Gestione

Gestione criteri di controllo 3/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Guangzheng Eye Hospital Group Co.,Ltd., Annual General Meeting, May 20, 2024

High number of new directors

High number of new directors

Guangzheng Eye Hospital Group Co., Ltd., Annual General Meeting, May 20, 2022

Recent updates

Guangzheng Eye Hospital Group Co.,Ltd. to Report Q3, 2024 Results on Oct 25, 2024

Second quarter 2024 earnings released

Guangzheng Eye Hospital Group Co.,Ltd. to Report First Half, 2024 Results on Aug 28, 2024

Guangzheng Eye Hospital Group Co.,Ltd. (SZSE:002524) May Have Run Too Fast Too Soon With Recent 28% Price Plummet

First quarter 2024 earnings released: CN¥0.04 loss per share (vs CN¥0.02 loss in 1Q 2023)

Guangzheng Eye Hospital Group Co.,Ltd., Annual General Meeting, May 20, 2024

Guangzheng Eye Hospital Group Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024

Guangzheng Eye Hospital Group Co., Ltd.'s (SZSE:002524) Shares Climb 26% But Its Business Is Yet to Catch Up

Guangzheng Eye Hospital Group Co., Ltd. to Report Fiscal Year 2023 Results on Apr 25, 2024

Third quarter 2023 earnings released: EPS: CN¥0.01 (vs CN¥0.42 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.02 (vs CN¥0.051 loss in 2Q 2022)

New major risk - Revenue and earnings growth

First quarter 2023 earnings released: CN¥0.02 loss per share (vs CN¥0.07 loss in 1Q 2022)

Now 22% undervalued after recent price drop

Now 21% undervalued after recent price drop

Now 21% undervalued

High number of new directors

Now 21% undervalued

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CN¥0.42 (vs CN¥0.03 loss in 3Q 2021)

Second quarter 2022 earnings released: CN¥0.051 loss per share (vs CN¥0.04 profit in 2Q 2021)

Full year 2021 earnings released: EPS: CN¥0.085 (vs CN¥0.085 in FY 2020)

High number of new directors

Guangzheng Eye Hospital Group Co., Ltd., Annual General Meeting, May 20, 2022

Full year 2021 earnings released: EPS: CN¥0.09 (vs CN¥0.085 in FY 2020)

Fujian Shencheng Energy Trade Co., Ltd entered into share transfer letter of intent to acquire 10% stake in Toksun Xin Tianshan Natural Gas Co., Ltd. from Guangzheng Eye Hospital Group Co., Ltd. (SZSE:002524) CNY 72 million.

Investor sentiment deteriorated over the past week

Third quarter 2021 earnings released: CN¥0.03 loss per share (vs CN¥0.08 profit in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.04 (vs CN¥0.056 loss in 2Q 2020)

Full year 2020 earnings released: EPS CN¥0.08 (vs CN¥0.14 in FY 2019)

New 90-day low: CN¥10.03

New 90-day low: CN¥10.61

New 90-day low: CN¥11.46

New 90-day high: CN¥13.40

Guangzheng Group Co.,Ltd to Report Q3, 2020 Results on Oct 23, 2020

New 90-day high - CN¥13.28

Guangzheng Group Co.,Ltd to Report First Half, 2020 Results on Aug 25, 2020

AMMINISTRATORE DELEGATO

Mandato

Compensazione

Gruppo dirigente

Durata media

Età media

Membri del Consiglio di amministrazione

Durata media

Età media